Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Next Deadline
635 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-04-27)
Due Date
April 27, 2027
Grace Period Ends
October 27, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 1, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 1, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 1, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 28, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 28, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 28, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 28, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 28, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Oct 28, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Nov 8, 2023 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| May 10, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 10, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 10, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 4, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Apr 27, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 25, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Mar 24, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 26, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 25, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 25, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 17, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 3, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Feb 3, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 3, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 3, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Aug 4, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 9, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 9, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 20, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 29, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 28, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 28, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 28, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 15, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 15, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 15, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 7, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 24, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 22, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing temporary use of a web based software platform for cancer risk assessment, diagnosis, treatment, and monitoring; providing temporary use of a web based software platform for bioinformatics analysis for medical and oncological diagnostic and personalized treatment purposes
First Use Anywhere:
Jul 8, 2020
First Use in Commerce:
Jul 8, 2020
Class 044
Oncological solutions portfolio consisting of diagnostic services in the field of medicine, medical testing for cancer risk assessment, diagnosis, treatment, and monitoring; bioinformatics analysis for medical and oncological diagnostic and personalized treatment purposes; consulting services in the field of oncological diagnosis and treatment; health care services, namely, leveraging health monitoring and data science to provide cancer diagnosis and treatment to patients
First Use Anywhere:
Jul 8, 2020
First Use in Commerce:
Jul 8, 2020
Additional Information
Pseudo Mark
SEMA FOUR SIGNAL
Classification
International Classes
042
044